Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : U.S. administers 407.4 mln doses of COVID-19 vaccines -CDC

10/16/2021 | 03:56pm EST

Oct 16 (Reuters) - The United States has administered 407,446,961 doses of COVID-19 vaccines as of Saturday morning and distributed 494,918,755 doses, the Centers for Disease Control and Prevention said.

Thee figures are up from the 406,570,875 vaccine doses the CDC said had gone into arms by Oct. 15 out of 493,139,295 doses delivered.

The agency said 218,562,924 people had received at least one dose while 188,902,483 people were fully vaccinated as of 6 a.m. ET Saturday.

The CDC tally includes two-dose vaccines from Moderna and Pfizer/BioNTech , and Johnson & Johnson's one-shot vaccine.

Over 10.1 million people have received a booster dose of either the Pfizer or Moderna vaccine since Aug. 13, when the U.S. authorized a third dose of the vaccines for those with compromised immune systems. The authorization for booster shots has since been broadened to a wider population. (Reporting by Bhargav Acharya in Bengaluru; Editing by Leslie Adler)


ę Reuters 2021
All news about MODERNA, INC.
07:26aSpecial Report-U.S. rushed contracts to COVID-19 suppliers with troubled plants
RE
05:32aModerna Agrees to Supply the UK With Additional 60 Million COVID-19 Vaccine Doses
MT
05:10aHARVARD UNIVERSITY : Moderna edges out Pfizer vaccine in head-to-head comparison; Large-sc..
AQ
12:26aModerna To Ready Omicron Booster Shot For US FDA Approval By March 2022
MT
12/01WRAPUP 6-U.S., Germany plan new restrictions as Omicron rattles investors
RE
12/01UK Secures 114 Million Additional COVID-19 Shots From Pfizer/BioNTech, Moderna
MT
12/01Moderna Announces Supply Agreement with the UK for Additional 60 Million Doses of Moder..
BU
12/01U.S. administers 462.3 mln doses of COVID-19 vaccines - CDC
RE
12/01UK agrees deals for 114 million more Moderna and Pfizer COVID-19 doses
RE
12/01U.S. CDC Says Administered 462.3 Million Doses Of Covid-19 Vaccine As Of Dec 1
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 17 449 M - -
Net income 2021 11 169 M - -
Net cash 2021 12 344 M - -
P/E ratio 2021 11,8x
Yield 2021 -
Capitalization 126 B 126 B -
EV / Sales 2021 6,51x
EV / Sales 2022 5,00x
Nbr of Employees 1 300
Free-Float 90,5%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Last Close Price 310,61 $
Average target price 272,53 $
Spread / Average Target -12,3%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.197.32%125 937
LONZA GROUP AG28.34%58 955
IQVIA HOLDINGS INC.44.70%49 527
SEAGEN INC.-9.64%28 937
CELLTRION, INC.-41.09%24 625
ICON PUBLIC LIMITED COMPANY40.00%22 219